StonvexLoading…
StonvexCore line items from INBS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $3.05M | $3.11M | $1.26M | $437.15K |
Operating Income | $-10.64M | $-10.28M | $-12.60M | $-8.34M |
Net Income | $-10.57M | $-10.16M | $-10.63M | $-8.31M |
EPS (Diluted) | $-2.00 | $-6.38 | $-127.00 | $-11.33 |
Total Assets | $8.25M | $13.78M | $10.35M | $12.35M |
Total Liabilities | $5.44M | $5.60M | $6.67M | $5.81M |
Cash & Equivalents | $1.02M | $6.30M | $1.54M | $8.24M |
Free Cash Flow OCF − CapEx | $-9.91M | $-9.79M | Not available | Not available |
Shares Outstanding | 7.32M | 3.46M | 194.20K | 14.89M |